Michael Hagele Has Some Important Ideas on Being an Entrepreneur
Posted on : 03-11-2018 By : Samantha Pointer
Michael Hagele began his illustrious professional career with a very humble and sometimes very unenjoyable job: Working at a car was during the winter in Chicago. But he then entered his long career in business and technology by earning his B.A. from the University of Iowa and his J.D. from the University of California at Berkeley. He is both an outside general counsel for and investor in a number of technology companies. He has garnered a vast amount of experience in the international internet, telecommunications, software, and hardware fields. View…
Read More
0 Comments
Andrew Rocklage: Bringing Innovation to Pharmaceutical Industry
Posted on : 05-22-2017 By : Samantha Pointer
Andrew Rocklage is widely known and famous in pharmaceutical and Biopharmaceutical sectors. He is an attorney and an excellent manager in the pharmaceutical industry. He has been able to set up his business as well. He owns Sky Zone Trampoline Park, a firm he had founded some years ago. Andrew has also a huge stake in pharmaceutical industry as he has ventured as a partner with 5AM Ventures, which is a leading medicine company in the country. Besides his education training in Law, Andrew is also an excellent and promising…
Read More
0 Comments
Dr. Scott M Rocklage Doing Great Things in the Pharmaceutical Industry
Posted on : 05-22-2017 By : Samantha Pointer
5AM Venture capitalists are risk-takers who finances small startups with the hope that they will be profitable in future. Currently, there are many profitable ventures in the healthcare and pharmaceutical market, and Dr. Scott Rocklage knows this better than anyone else. Dr. Scott works as a Managing Partner at 5AM Ventures, and initially, he joined the firm as a venture capitalist back in 2003.   Dr. Rocklage has over three decades experience in the pharmaceutical sector, having held executive positions for several corporations in the industry. These include being the…
Read More
0 Comments